These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 30583680)
1. A Pharmacological Strategy Using Stemofoline for more Efficacious Chemotherapeutic Treatments Against Human Multidrug Resistant Leukemic Cells. Umsumarng S; Mapoung S; Yodkeeree S; Pyne SG; Limtrakul Dejkriengkraikul P Asian Pac J Cancer Prev; 2018 Dec; 19(12):3533-3543. PubMed ID: 30583680 [TBL] [Abstract][Full Text] [Related]
2. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
4. Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationships. Umsumarng S; Pitchakarn P; Yodkeeree S; Punfa W; Mapoung S; Ramli RA; Pyne SG; Limtrakul P Phytomedicine; 2017 Oct; 34():182-190. PubMed ID: 28899501 [TBL] [Abstract][Full Text] [Related]
5. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways. Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697 [TBL] [Abstract][Full Text] [Related]
8. The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes. Eid SY; Althubiti MA; Abdallah ME; Wink M; El-Readi MZ Phytomedicine; 2020 Oct; 77():153280. PubMed ID: 32712543 [TBL] [Abstract][Full Text] [Related]
9. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells. Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065 [TBL] [Abstract][Full Text] [Related]
10. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment. Mashayekhi S; Yousefi B; Tohidi E; Darband SG; Mirza-Aghazadeh-Attari M; Sadighparvar S; Kaviani M; Shafiei-Irannejad V; Kafil HS; Karimian A; Jadidi-Niaragh F; Majidinia M J Cell Biochem; 2019 Sep; 120(9):15719-15729. PubMed ID: 31087712 [TBL] [Abstract][Full Text] [Related]
12. Effects of P-glycoprotein and its inhibitors on apoptosis in K562 cells. Zu Y; Yang Z; Tang S; Han Y; Ma J Molecules; 2014 Aug; 19(9):13061-75. PubMed ID: 25157469 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle. Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184 [TBL] [Abstract][Full Text] [Related]
14. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo. Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682 [TBL] [Abstract][Full Text] [Related]
15. Retaining cytotoxic activity of anthrapyridone CO1 against multidrug resistant cells is related to the ability to induce concomitantly apoptosis and lysosomal death of leukaemia HL60/VINC and HL60/DOX cells. Nowak R; Tarasiuk J J Pharm Pharmacol; 2013 Jun; 65(6):855-67. PubMed ID: 23647679 [TBL] [Abstract][Full Text] [Related]
16. Reversal of human multi-drug resistance leukaemic cells by stemofoline derivatives via inhibition of P-glycoprotein function. Umsumarng S; Pitchakarn P; Sastraruji K; Yodkeeree S; Ung AT; Pyne SG; Limtrakul P Basic Clin Pharmacol Toxicol; 2015 May; 116(5):390-7. PubMed ID: 25265513 [TBL] [Abstract][Full Text] [Related]
17. Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein. Sun Y; Liu W; Wang C; Meng Q; Liu Z; Huo X; Yang X; Sun P; Sun H; Ma X; Peng J; Liu K J Cell Physiol; 2019 Apr; 234(4):3685-3696. PubMed ID: 30171603 [TBL] [Abstract][Full Text] [Related]
18. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells. Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665 [TBL] [Abstract][Full Text] [Related]